# EDGAR Filing Document

**Accession Number:** 0001803901
**File Stem:** 0000000000-25-008860
**Filing Date:** 2025-8
**Character Count:** 5172
**Document Hash:** 4cad3809a0fbee9d18866feb333aa4a8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008860.hdr.sgml**: 20260123

**ACCESSION NUMBER**: 0000000000-25-008860

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250820

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Talkspace, Inc.
- **CENTRAL INDEX KEY:** 0001803901
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 844636604
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-39314

**BUSINESS ADDRESS:**
- **STREET 1:** 622 THIRD AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** (212) 284-7206

**MAIL ADDRESS:**
- **STREET 1:** 2578 BROADWAY #607
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10025

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hudson Executive Investment Corp.
- **DATE OF NAME CHANGE:** 20200219
**PUBLIC REFERENCE ACCESSION NUMBER**: 0000950170-25-038107

## Text-Extract

```

                                                             August 20, 2025

Ian Harris
Chief Financial Officer
Talkspace, Inc.
622 Third Avenue
New York, NY 10017

        Re: Talkspace, Inc.
            Form 10-K for the Fiscal Year Ended December 31, 2024
            Filed March 12, 2025
            File No. 001-39314
Dear Ian Harris:

       We have limited our review of your filing to the financial statements
and related
disclosures and have the following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Form 10-K for the Year Ended December 31, 2024
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Year Ended December 31, 2024 compared to December 31, 2023
Revenues, page 48

1.     Please revise your disclosure in future filings to provide a more
comprehensive and
       substantive explanation including the significant reasons for the
increases and
       decreases in revenues by payor, including the impacts of changes in
pricing versus
       volume and a thorough discussion of any significant underlying trends.
We note that
       the majority of the paragraph following the table appears to simply
repeat the
       information provided by the table above it. Refer to Item 303(b)(2) of
Regulation S-K
       and SEC Release No. 33-8350.
2.     Throughout your discussion of results of operations, several of the
factors you note as
       contributing to variances between periods are not quantified as to their
magnitude.
       Please revise your disclosure in future filings to include quantitative
terms pursuant to
       Item 303(b) of Regulation S-K.
 August 20, 2025
Page 2

Consolidated Financial Statements
Note 12. Income Tax Expense, page 77

3.     We see your disclosure that the main reconciling item between the
statutory tax rate of
       the company and the effective tax rate is the valuation allowance. While
that may
       have been in case in prior years it does not appear to be the case in
fiscal 2024. Please
       revise your disclosure in future filings to reflect the current
fluctuations in valuation
       allowance, considering the income in fiscal 2024 compared to losses in
prior years.
Note 13. Variable Interest Entities (VIEs), page 79

4.     Revise future filings to disclose the nature of any restrictions on a
consolidated VIE's
       assets and on the settlement of its liabilities in your statement of
financial position and
       the existence of any lack of recourse if creditors (or beneficial
interest holders) of
       your consolidated VIEs have no recourse to the general credit of the
primary
       beneficiary. Reference ASC 810-10-50-3. Note that assets of consolidated
VIEs that
       can only be used to settle the obligations of the consolidated VIEs, and
liabilities for
       which creditors do not have recourse to the general credit of the
primary beneficiary
       are required to separately present on the face of your balance sheets
under ASC 810-
       10-45-25.
        In closing, we remind you that the company and its management are
responsible for
the accuracy and adequacy of their disclosures, notwithstanding any review,
comments,
action or absence of action by the staff.

       Please contact Julie Sherman at 202-551-3640 or Kristin Lochhead at
202-551-3664
with any questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of
Industrial Applications and
                                                              Services

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._